A Study of Tulmimetostat DZR123 (CPI-0209) in Patients With Advanced Solid Tumors and Lymphomas
Novartis
Novartis
ImmVira Pharma Co. Ltd
Eli Lilly and Company
CSPC ZhongQi Pharmaceutical Technology Co., Ltd.
Curis, Inc.
Shenzhen BinDeBio Ltd.
Novartis
Valerio Therapeutics